Hikma Pharmaceutical | Salgsomkostninger Og Administration



Selling And Administration Expenses Lave om Dato
Almirall EUR -50222000 162.22M 2024-06
argenx SE USD 285.94M 8.24M 2024-12
AstraZeneca USD 3.59B 1.96B 2025-03
Autolus Therapeutics Ltd 33.68M 6.35M 2024-12
Bayer EUR 4.34B 610M 2024-12
Fresenius EUR 769M 68M 2024-12
Galapagos EUR 43.8M 2.55M 2025-03
Genmab DKK 1.25B 384M 2024-12
GlaxoSmithKline GBP 2.06B 603M 2025-03
GRIFOLS EUR 269.48M 49.95M 2024-12
Hikma Pharmaceutical USD 280M 4M 2024-06
Merck EUR 1.05B 361M 2024-12
Orion EUR 84.3M 30.6M 2025-03
Recordati EUR 149.34M 15.49M 2024-09
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.22B 980M 2025-03
UCB EUR 533M 434M 2024-06



Hikma Pharmaceutical Salgsomkostninger Og Administration - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2025.